✦ LIBER ✦

Outcomes and Costs of Risperidone versus Olanzapine in Patients with Chronic Schizophrenia or Schizoaffective Disorders: A Markov Model

✍ Scribed by Montserrat Vera-Llonch; Thomas E Delea; Erin Richardson; Marcia Rupnow; Amy Grogg; Gerry Oster

Book ID: 109078445
Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 138 KB
Volume: 7
Category: Article
ISSN: 1098-3015
DOI: 10.1111/j.1524-4733.2004.75008.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comments to the Editor on “Outcomes and

Comments to the Editor on “Outcomes and Costs of Risperidone versus Olanzapine in Patients with Chronic Schizophrenia or Schizoaffective Disorders: A Markov Model”

📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 36 KB

Comparative effects of risperidone and o

Comparative effects of risperidone and olanzapine on cognition in elderly patients with schizophrenia or schizoaffective disorder

✍ Philip D. Harvey; Judy A. Napolitano; Lian Mao; Georges Gharabawi 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 2 views

## Abstract ## Objective To examine the effects of risperidone and olanzapine on cognitive functioning in elderly patients with schizophrenia or schizoaffective disorder. ## Method One hundred seventy‐six elderly inpatients and outpatients with schizophrenia or schizoaffective disorder were enro

Resource Utilization and Costs of Schizo

Resource Utilization and Costs of Schizophrenia Patients Treated with Olanzapine versus Quetiapine in a Medicaid Population

✍ Andrew P. Yu; Pavel Atanasov; Rym Ben-Hamadi; Howard Birnbaum; Michael D. Stensl 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

Efficacy and tolerability of quetiapine

Efficacy and tolerability of quetiapine in patients with schizophrenia who switched from haloperidol, olanzapine or risperidone

✍ Ilkka Larmo; André de Nayer; Elmar Windhager; Irmansyah; Bernhard Lindenbauer; H 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB 👁 2 views

## Abstract A __post hoc__ analysis of the SPECTRUM trial was carried out to evaluate whether the improvements in efficacy and tolerability gained on switching to quetiapine occurred consistently for patients previously treated with either: haloperidol (__n__ = 43); olanzapine (__n__ = 66); or risp

An observational study of the effectiven

An observational study of the effectiveness and safety of intramuscular olanzapine in the treatment of acute agitation in patients with bipolar mania or schizophrenia/schizoaffective disorder

✍ Franca Centorrino; Adam L. Meyers; Jonna Ahl; Stephanie L. Cincotta; Leslie Zun; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 2 views

## Abstract ## Objective To determine the effect of intramuscular (IM) olanzapine in severely agitated patients. ## Methods This was an open‐label multicenter 1‐week observational study of IM olanzapine treatment in severely agitated inpatients and psychiatric emergency services with bipolar man

The impact upon extra-pyramidal side eff

The impact upon extra-pyramidal side effects, clinical symptoms and quality of life of a switch from conventional to atypical antipsychotics (risperidone or olanzapine) in elderly patients with schizophrenia

✍ C. W. Ritchie; E. Chiu; S. Harrigan; K. Hall; A. Hassett; S. Macfarlane; M. Mast 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB 👁 2 views

## Abstract ## Background Atypical antipsychotics are commonly used in the management of schizophrenia in late life with evidence suggesting they induce lower rates of motor disturbance, but have similar efficacy to conventional antipsychotics. Trials in the elderly have been either retrospective,